Treatment of central serous chorioretinopathy with beta-blocker metipranolol

Aim: The purpose of this study was to evaluate the effect of the systemically administered betablocker metipranolol on the course of central serous chorioretinopathy (CSC). Methods: A prospective double-blind study involving 48 patients with a first attack of CSC not exceeding two weeks and who agre...

Full description

Bibliographic Details
Published in:Biomedical Papers
Main Authors: Oldrich Chrapek, Barbora Jirkova, Vít Kandrnal, Jiri Rehak, Martin Sin
Format: Article
Language:English
Published: Palacký University Olomouc, Faculty of Medicine and Dentistry 2015-03-01
Subjects:
Online Access:https://biomed.papers.upol.cz/artkey/bio-201501-0018_Treatment_of_central_serous_chorioretinopathy_with_beta-blocker_metipranolol.php